Your browser doesn't support javascript.
loading
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.
Doria-Rose, Nicole A; Altae-Tran, Han R; Roark, Ryan S; Schmidt, Stephen D; Sutton, Matthew S; Louder, Mark K; Chuang, Gwo-Yu; Bailer, Robert T; Cortez, Valerie; Kong, Rui; McKee, Krisha; O'Dell, Sijy; Wang, Felicia; Abdool Karim, Salim S; Binley, James M; Connors, Mark; Haynes, Barton F; Martin, Malcolm A; Montefiori, David C; Morris, Lynn; Overbaugh, Julie; Kwong, Peter D; Mascola, John R; Georgiev, Ivelin S.
Afiliação
  • Doria-Rose NA; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • Altae-Tran HR; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • Roark RS; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • Schmidt SD; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • Sutton MS; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • Louder MK; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • Chuang GY; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • Bailer RT; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • Cortez V; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
  • Kong R; Program in Molecular and Cellular Biology, University of Washington, Seattle, WA, United States of America.
  • McKee K; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • O'Dell S; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • Wang F; Vaccine Research Center, National Institutes of Health, Bethesda, MD, United States of America.
  • Abdool Karim SS; Vanderbilt Vaccine Center, Vanderbilt University, Nashville, TN, United States of America.
  • Binley JM; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
  • Connors M; Department of Epidemiology, Columbia University, New York, NY, United States of America.
  • Haynes BF; San Diego Biomedical Research Institute, San Diego, CA, United States of America.
  • Martin MA; HIV-Specific Immunity Section, National Institutes of Health, Bethesda, MD, United States of America.
  • Montefiori DC; Duke University Human Vaccine Institute, Durham, NC, United States of America.
  • Morris L; Departments of Medicine and Immunology, Duke University School of Medicine, Durham, NC, United States of America.
  • Overbaugh J; Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery at Duke University, Durham, NC, United States of America.
  • Kwong PD; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Mascola JR; Duke University Human Vaccine Institute, Durham, NC, United States of America.
  • Georgiev IS; Department of Surgery, Duke University School of Medicine, Durham, NC, United States of America.
PLoS Pathog ; 13(1): e1006148, 2017 01.
Article em En | MEDLINE | ID: mdl-28052137

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Infecções por HIV / HIV-1 / Vacinas contra a AIDS / Mapeamento de Epitopos / Epitopos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Infecções por HIV / HIV-1 / Vacinas contra a AIDS / Mapeamento de Epitopos / Epitopos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article